Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Regulatory Reads, February 2018: Funding, Digital Health And Program Alignment

Executive Summary

While the overall FY 2019 Trump administration budget request submitted last month was widely criticized, the high numbers slated for US FDA in the document attracted positive attention in the life-sciences space, and among Medtech Insight readers. Also popular among US regulatory and policy content last month: coverage of a digital-health gathering, program alignment insights and stories on FDA restructuring, federal enforcement and adverse events trends.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT122280

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel